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Urinary tract infections are extremely common. Indeed, the
lifetime probability that a woman will have a symptomatic
urinary tract infection has been estimated to be between 40%
and 50%. Each year in the USA, 3% of women consult for urinary
infections [1]. In France, there is a lack of epidemiological
studies on community-acquired urinary tract infections. Nev-
ertheless, the annual incidence has been estimated to be 4–
6 million cases, based on the fact that urinary tract infections
account for 1–2.1% of the activity of general practitioners [2].
Up to now, epidemiological consideration of urinary
infections has focused on predisposing factors, and the
evidence that Escherichia coli urinary tract infections could be
epidemic has emerged only recently.
A study published in 2011 [3] showed that, in California,
community-acquired urinary tract infections in women were
caused by a single, previously unrecognized, clonal group of
multidrug-resistant E. coli, called clonal group A. This clonal
group accounted for 51% of urinary tract infections caused by
E. coli strains that were resistant to trimethoprim–sulphameth-
oxazole. A previously described study in England [4] showed
that up to 26% of the infections diagnosed between 1986 and
1987 were related to a single clone that caused urinary tract
infections but also septicaemia, pneumonia, and meningitis, and
caused three deaths. The means of transmission were not
clearly identiﬁed. Below, several sources are discussed, espe-
cially as multiresistant and extended-spectrum b-lactam-
ase-producing E. coli strains are circulating in the community.
Several studies in the USA and in The Netherlands
(published in CMI) have shown that multiresistant strains of
E. coli found in poultry could have similar proﬁles to strains
found in hospitals.
A recently published study [5] showed the probable genesis
of the resistance of community strains of E. coli, investigating in
France the contamination of the river (Doubs), which crosses
the city of Besancon. The load of multiresistant E. coli strains in
the river is signiﬁcantly higher at the exit of the city than at the
entrance to the city.
This seems to be related to the fact that billions of
resistance genes entered the hospital waste water network.
Microorganisms were destroyed by the waste water treatment
plant (WWTP), but the genes continued to circulate and to
transform E. coli strains present in the water downstream. This
is very concerning; it shows the spread of extended-spectrum
b-lactamase-producing E. coli from the WWTP by water being
drawn from hospitals, carrying resistance genes. Also, the
sludge produced by the WWTP have been used as an
agricultural fertilizer in surrounding regions, and has thus
transferred considerable amounts of resistance genes. Thus, it
is likely that one of the sources of the spread of epidemic
clones of E. coli and antimicrobial resistance in E. coli, and
probably of other microorganisms, is the use of sludge from
WWTPs after drainage of the microorganisms from the
hospital.
We are facing a terrible epidemic of E. coli. This is probably
the most common cause of bacterial infection, with an often
clonal evolution and and an unknown epidemic evolution. The
level of resistance achieved by E. coli is therefore all the more
concerning. Considering that the mortality rates of blood-
stream infections caused by E. coli can vary between 10% and
16%, depending on the age of patients [6], the epidemic of
E. coli is probably a major public health concern, causing a risk
of mortality that has nothing to do with the emerging
respiratory virus [7].
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